150 related articles for article (PubMed ID: 9739158)
1. MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters.
Kitayama S; Mitsuhata C; Davis S; Wang JB; Sato T; Morita K; Uhl GR; Dohi T
Biochim Biophys Acta; 1998 Sep; 1404(3):305-13. PubMed ID: 9739158
[TBL] [Abstract][Full Text] [Related]
2. Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
Kitayama S; Morita K; Dohi T
Eur J Pharmacol; 1996 Aug; 309(1):107-9. PubMed ID: 8864700
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
Pifl C; Giros B; Caron MG
J Neurosci; 1993 Oct; 13(10):4246-53. PubMed ID: 8410185
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
Pifl C; Hornykiewicz O; Giros B; Caron MG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
[TBL] [Abstract][Full Text] [Related]
5. Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter.
Lee SH; Rhee J; Koh JK; Lee YS
Neurosci Lett; 1996 Aug; 214(2-3):199-201. PubMed ID: 8878118
[TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-4-phenylpyridinium-induced down-regulation of dopamine transporter function correlates with a reduction in dopamine transporter cell surface expression.
Chagkutip J; Vaughan RA; Govitrapong P; Ebadi M
Biochem Biophys Res Commun; 2003 Nov; 311(1):49-54. PubMed ID: 14575693
[TBL] [Abstract][Full Text] [Related]
7. Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro.
Lehmensiek V; Tan EM; Schwarz J; Storch A
Neuroreport; 2002 Jul; 13(10):1279-83. PubMed ID: 12151787
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine.
Mitsuhata C; Kitayama S; Morita K; Vandenbergh D; Uhl GR; Dohi T
Brain Res Mol Brain Res; 1998 May; 56(1-2):84-8. PubMed ID: 9602072
[TBL] [Abstract][Full Text] [Related]
9. Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA.
Kitayama S; Shimada S; Uhl GR
Ann Neurol; 1992 Jul; 32(1):109-11. PubMed ID: 1642464
[TBL] [Abstract][Full Text] [Related]
10. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
13. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of MPP(+) incorporation into cerebellar granule cells.
González-Polo RA; Mora A; Clemente N; Sabio G; Centeno F; Soler G; Fuentes JM
Brain Res Bull; 2001 Sep; 56(2):119-23. PubMed ID: 11704348
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
16. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
Lee SH; Cho HK; Son H; Lee YS
Neuroreport; 1997 Jul; 8(11):2591-4. PubMed ID: 9261833
[TBL] [Abstract][Full Text] [Related]
17. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Siebert GA; Pond SM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
19. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells.
Stephans SE; Miller GW; Levey AI; Greenamyre JT
Neurotoxicology; 2002 Oct; 23(4-5):569-80. PubMed ID: 12428729
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
